Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?

Mosca AntonellaAndrea Pietrobattista Giuseppe Maggiore

Published in: Pediatric reports (2024)

The term "non-alcoholic fatty liver disease" (NAFLD) has been, for a long time, used to describe the spectrum of liver lesions encompassing steatosis, steatohepatitis (NASH), and steatotic cirrhosis [...].

Keyphrases

preterm infants
gestational age
insulin resistance
high fat diet
type diabetes
stem cells
preterm birth
high fat diet induced
metabolic syndrome
mesenchymal stem cells
replacement therapy
cell therapy
smoking cessation